Literature DB >> 3137529

Reactivity of monofunctional cis-platinum adducts as a function of DNA sequence.

J M Malinge1, M Leng.   

Abstract

The purpose of this work was to study the chemical reactivity of monofunctional cis-platinum-nucleic acid adducts as a function of nucleic acid sequence. The first part of the paper deals with the formation of these adducts. It is shown that the ternary nucleic acid-cis-platinum-ethidium bromide complexes in which ethidium bromide and nucleotide residues are cross-linked by cis-platinum, are relatively unstable at 37 degrees C. In the presence of acridine, ethidium bromide (but not cis-platinum) is slowly released which leads to the formation of monofunctional cis-platinum-nucleic acid adducts. After removal of acridine, the monofunctional adducts react further to become bifunctional. The second part of the paper deals with the kinetics of disappearance of the monofunctional adducts in several polynucleotides but not in poly(dG).poly(dC). When the adducts possess a chloride ligand, the limiting step in the cross-linking is the rate of aquation reaction of the chloride ligand. The rate constants are an order of magnitude larger when the monofunctional adducts do not possess a chloride ligand. In both the cases, the rate constants are apparently independent of the nucleic acid sequence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137529      PMCID: PMC338433     

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  The mechanism of action of antitumor platinum compounds.

Authors:  J J Roberts; A J Thomson
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1979

2.  Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).

Authors:  A Eastman
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

3.  Ethidium bromide changes the nuclease-sensitive DNA binding sites of the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  T D Tullius; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

4.  Stabilization of (dG-dC)n.(dG-dC)n in the Z conformation by a crosslinking reaction.

Authors:  H Castleman; L H Hanau; B F Erlanger
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

5.  Immunochemical studies of DNA modified by cis-dichlorodiammineplatinum(II) in vivo and in vitro.

Authors:  B Malfoy; B Hartmann; J P Macquet; M Leng
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

6.  Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.

Authors:  K Micetich; L A Zwelling; K W Kohn
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

7.  Alteration and activation of sequence-specific cleavage of DNA by bleomycin in the presence of the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  P K Mascharak; Y Sugiura; J Kuwahara; T Suzuki; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

8.  Thiourea prevents cytotoxicity and mutagenicity, but not sister-chromated exchanges in V79 cells treated with cis-diaminedichloroplatinum (II).

Authors:  M O Bradley; S Patterson; L A Zwelling
Journal:  Mutat Res       Date:  1982-09       Impact factor: 2.433

9.  Enzymatic synthesis of deoxyribonucleic acids with repeating sequences. A new repeating trinucleotide deoxyribonucleic acid, d(T-C-C)n-d(G-G-A)n.

Authors:  A R Morgan; M B Coulter; W F Flintoff; V H Paetkau
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

10.  Comparison between poly(dG-dC).poly(dG-dC) and DNA modified by cis-diamminedichloroplatinum (II): immunological and spectroscopic studies.

Authors:  A Rahmouni; J M Malinge; A Schwartz; M Leng
Journal:  J Biomol Struct Dyn       Date:  1985-10
View more
  3 in total

1.  Possible catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium.

Authors:  F Gaucheron; J M Malinge; A J Blacker; J M Lehn; M Leng
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  The reaction of platinum(II) complexes with DNA. Kinetics of intrastrand crosslink formation in vitro.

Authors:  F Bernges; E Holler
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

3.  Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium.

Authors:  J M Malinge; M Sip; A J Blacker; J M Lehn; M Leng
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.